By Stella Goh

According to the Russia’s president Vladimir Putin, has claimed victory in the race for coronavirus vaccine after it became the first country to officially register and declare it ready for use, despite less than two months of human testing and not completing the final trials.

The vaccine was named as “Sputnik V” to commemorate the world’s first satellite launched by Soviet Union. There is only about 10% of clinical trials are successful and some scientists fear Moscow may be putting national prestige before the safety. Putin also said that the vaccine developed by Moscow’s Gamaleya Institute would be administered to people, including doctors, on a voluntary basis, and would be ready soon. He said Russia plans to be able to produce 5 million doses a month by December-January.

After the news spread, all the glove counters began to fall tremendously, resulting a huge loss of RM22 billion for the big four glove counter’s market value. Top Glove suffered a serious declined, while the other glove counters also did not perform well at the moment.

In  addition, the British media has revealed the Russian official documents showing that there are 31 out of 38 of volunteers who had been tested for the vaccine began to suffer from its side effects such as pain, swelling and having a high body temperature on the 42^nd days after the test for the vaccine and there are about 144 adverse reactions were recorded. According to the World Health Organization (WHO), the vaccine approved must go through a rigorous review of safety information.

The U.S. government also questioned the results of Russian vaccine test. According to the White House Counselor Kellyanne Conway, dismissing the announcement of a Russian vaccine for the coronavirus, on Tuesday 11August suggested that the U.S. has superior safety standards and current domestic trials are better positioned for success.

Join us now in stockpick2u and we will share our views on the company and details of shareholders’ meeting.

-------------------------------------------------------------

Stockpick2u
https://www.stockpick2u.com/plans-pricing
 

Please contact us：
012-6644 828

WhatsApp link:
https://bit.ly/33pEKcS

Website: www.stockpick2u.com

Facebook: https://www.facebook.com/stockpick2u/?ref=bookmarks

Services: General Meeting Information, Company Fundamentals Sharing

Disclaimer:

The above data are purely based on personal views. The content above does not contain any trading advice, and only can be used as learning and information purposes. Please analyze by yourself, understand the risks, and discuss the nature of investment with professional financial advisors.

Stockpick2u is not responsible for any accuracy, completeness, correctness, validity of any shared content and opinion. All misunderstandings, errors, omissions, delays in information are not responsible for any loss incurred.